Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 5 Ovarian Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Retinoblastoma 2 Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous-Cell Lung Cancer 1 Retinal Neoplasms 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Resectable Non-small Cell Lung Cancer 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 NSCLC 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Bronchogenic 1 Carcinoma 1

Interventions

Carboplatin 75 Paclitaxel 68 Bevacizumab 44 Taxes 22 Cyclophosphamide 21 pembrolizumab 19 Gemcitabine 19 Cisplatin 18 Topotecan 17 Hyperthermic Intraperitoneal Chemotherapy 14 olaparib 13 liposomal doxorubicin 13 Immunoglobulin G 13 Disulfides 13 Specimen Handling 11 Drug Therapy 11 niraparib 10 Cytoreduction Surgical Procedures 10 Magnetic Resonance Spectroscopy 9 sargramostim 7 Surveys and Questionnaires 7 Doxorubicin 7 Docetaxel 7 durvalumab 6 Platinum 6 Nivolumab 6 Letrozole 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 Biopsy 6 Albumin-Bound Paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fallopian Tube Neoplasms × Platinum Compounds × Clear all

NCT02489006 2024-01-17

NEO

University Health Network, Toronto

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡